浏览全部资源
扫码关注微信
Top 10 Academic Progress of Traditional Chinese Medicine in 2022
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 29, Issue 15, Pages: 179-198(2023)
- 作者机构：
- 作者简介：
- 基金信息：
DOI：10.13422/j.cnki.syfjx.20231065
CLC： R2;R28;G353.11;R932Published：05 August 2023，
Published Online：30 May 2023，
Received：25 May 2023，
- 稿件说明：
扫 描 看 全 文
.2022年度中医药十大学术进展[J].中国实验方剂学杂志,2023,29(15):179-198.
.Top 10 Academic Progress of Traditional Chinese Medicine in 2022[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(15):179-198.
.2022年度中医药十大学术进展[J].中国实验方剂学杂志,2023,29(15):179-198. DOI： 10.13422/j.cnki.syfjx.20231065.
.Top 10 Academic Progress of Traditional Chinese Medicine in 2022[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(15):179-198. DOI： 10.13422/j.cnki.syfjx.20231065.
摘要
背景
2
为贯彻落实党的二十大精神和《中共中央国务院关于促进中医药传承创新发展的意见》，定期梳理总结中医药研究成果，动态呈现中医药学术进展，充分发挥学术团体的学术引领作用，中华中医药学会组织开展了2022年度中医药十大学术进展遴选工作。本年度遴选工作坚持“四个面向”，破除“四唯”，突出解决临床问题、回答科学问题、引领行业发展，体现探索性与前瞻性、创新性与突破性，聚焦中医药基础研究和应用基础研究领域取得的新规律、新发现、新方法、新产品、新理论。经动态收集、初审、复审、终审等工作程序，确定2022年度中医药十大学术进展。
Abstract
Background
2
In order to implement the spirit of the 20
th
National Congress of the Communist Party of China， and the
Opinions on Promoting the Inheritance， Innovation and Development of Traditional Chinese Medicine
（
TCM
）， to regularly summarize the research results of TCM， to present the academic progress of TCM dynamically， and to give full play to the academic leadership of academic groups， the China Association of Chinese Medicine had organized the selection of the top 10 academic progress of TCM in 2022. The selection work adhered to the four orientations， eliminated the four only， highlighted the solution of clinical problems， answered scientific questions， led the development of the industry， reflected the exploratory and forward-looking， innovative and breakthrough， focused on new laws， new discoveries， new methods， new products， new theories in the field of basic research and applied basic research in TCM. After dynamic collection， preliminary examination， review and final judgment， the top 10 academic progress of TCM in 2022 were determined.
关键词
中医药（TCM）学术进展新型冠状病毒肺炎（COVID-19）糖尿病肾病针灸克罗恩病苓桂术甘汤靶点钩钓基因组图谱药物肝损伤
Keywords
traditional Chinese medicine（TCM）academic progresscorona virus disease 2019（COVID-19）diabetic nephropathyacupunctureCrohn's diseaseLinggui Zhugantangtarget hook fishinggenomic mapdrug-induced liver injury
references
ZHU N，ZHANG D，WANG W，et al.A novel coronavirus from patients with pneumonia in China，2019［J］.N Engl J Med，2020，382（8）：727-733.
中国疾病预防控制中心.新型冠状病毒肺炎疫情分布［EB/OL］．［2021-09-30］．http：//2019ncov.chinacdc.cn/2019-nCoV/global.htmlhttp://2019ncov.chinacdc.cn/2019-nCoV/global.html．
BURK M，EL-KERSH K，SAAD M，et al.Viral infection in community-acquired pneumonia：A systematic review and meta-analysis［J］.Eur Respir Rev，2016，25（140）：178-188.
王玉光，齐文升，马家驹，等.新型冠状病毒肺炎中医临床特征与辨证治疗初探［J］.中医杂志，2020，61（4）：281-285.
中华人民共和国国家卫生健康委员会．关于印发新型冠状病毒感染的肺炎诊疗方案（试行第四版）的通知［EB/OL］．［2020-01-27］．http：//www.gov.cn/zhengce/zhengceku/2020-01/28/content_5472673.htmhttp://www.gov.cn/zhengce/zhengceku/2020-01/28/content_5472673.htm.
SHAH M R，FATIMA S，KHAN S N，et al.Jinhua Qinggan granules for non-hospitalized COVID-19 patients：A double-blind，placebo-controlled，and randomized controlled trial［J］.Front Med （Lausanne），2022，9：928468.
CHEN H，GUO J，WANG C，et al.Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women：A retrospective review of medical records［J］.Lancet，2020，395（10226）：809-815.
AL-TAWFIQ J A，HOANG V T，LE BUI N，et al.The emergence of the omicron （B.1.1.529） SARS-CoV-2 variant：What is the impact on the continued pandemic？［J］.J Epidemiol Glob Health，2022，12（2）：143-146.
THAKUR V，RATHO R K.Omicron （B.1.1.529）：A new SARS-CoV-2 variant of concern mounting worldwide fear［J］.J Med Virol，2022，94（5）：1821-1824.
ZHANG L，LI Q，LIANG Z，et al.The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron［J］.Emerg Microbes Infect，2022，11（1）：1-5.
XIA L，SHI Y，SU J，et al.Shufeng Jiedu，a promising herbal therapy for moderate COVID-19：Antiviral and anti-inflammatory properties，pathways of bioactive compounds，and a clinical real-world pragmatic study［J］.Phytomedicine，2021，85：153390.
TAO Z，ZHANG L，FRIEDEMANN T，et al.Systematic analyses on the potential immune and anti-inflammatory mechanisms of Shufeng Jiedu capsule against severe acute respiratory syndrome coronavirus 2 （SARS-CoV-2）-caused pneumonia［J］.J Funct Foods，2020，75：104243.
CHEN B，GENG P，SHEN J，et al.Traditional Chinese medicine Jingyingubiao formula therapy improves the negative conversion rate of SARS-CoV2 in patients with mild COVID-19［J］.Int J Biol Sci，2022，18（15）：5641-5652.
HUANG K，ZHANG P，ZHANG Z，et al.Traditional Chinese medicine （TCM） in the treatment of COVID-19 and other viral infections：Efficacies and mechanisms［J］.Pharmacol Ther，2021，225：107843.
ZHAO Z Y，LI Y D，ZHOU L Y，et al.Prevention and treatment of COVID-19 using traditional Chinese medicine：A review［J］.Phytomedicine，2021，85：153308.
JI Z，HU H，QIANG X，et al.Traditional Chinese medicine for COVID-19：A network Meta-analysis and systematic review［J］.Am J Chin Med，2022，50（4）：883-925.
上海市新型冠状病毒感染中医药诊疗专家共识（2022春季版）编写组.上海市新型冠状病毒感染中医药诊疗专家共识（2022春季版）［J］.上海中医药杂志，2022，56（7）：5-6.
International Diabetes Federation.IDF Diabetes Atlas 2022 Reports［EB/OL］.［2023-05-18］https：//diabetesatlas.org/https://diabetesatlas.org/.
LI Y，TENG D，SHI X，et al.Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association：National cross sectional study［J］.BMJ，2020，369：m997.
THOMAS M C，BROWNLEE M，SUSZTAK K，et al.Diabetic kidney disease［J］.Nat Rev Dis Primers，2015，1：15018.
ZHANG L，LI P，XING C Y，et al.Efficacy and safety of Abelmoschus manihot for primary glomerular disease：A prospective，multicenter randomized controlled clinical trial［J］.Am J Kidney Dis，2014，64（1）：57-65.
LI P，LIN H，NI Z，et al.Efficacy and safety of Abelmoschus manihot for IgA nephropathy：A multicenter randomized clinical trial［J］.Phytomedicine，2020，76：153231.
SUN X，LI P，LIN H，et al.Efficacy and safety of Abelmoschus manihot in treating chronic kidney diseases：A multicentre，open-label and single-arm clinical trial［J］.Phytomedicine，2022，99：154011.
ZHAO J，TOSTIVINT I，XU L，et al.Efficacy of combined Abelmoschus manihot and irbesartan for reduction of albuminuria in patients with type 2 diabetes and diabetic kidney disease：A multicenter randomized double-blind parallel controlled clinical trial［J］.Diabetes Care，2022，45（7）：e113-e115.
岗卫娟，费宇彤，刘建平，等.提升针灸研究质量：现状、问题、思考和展望［J］.中国针灸，2023，43（1）：3-7.
ZHANG Y Q，JING X，GUYATT G.Improving acupuncture research：Progress，guidance，and future directions［J］.BMJ，2022，376：o487.
GANG W J，XIU W C，SHI L J，et al.Factors associated with the magnitude of acupuncture treatment effects （FAMOUS）：A Meta-epidemiological study of acupuncture randomised controlled trials［J］.BMJ Open，2022，12（8）：e060237.
FEI Y T，CAO H J，XIA R Y，et al.Methodological challenges in design and conduct of randomised controlled trials in acupuncture［J］.BMJ，2022，376：e064345.
ZHANG Y Q，JIAO R M，WITT C M，et al.How to design high quality acupuncture trials—A consensus informed by evidence［J］.BMJ，2022，376：e067476.
LU L M，ZHANG Y Q，TANG X R，et al.Evidence on acupuncture therapies is underused in clinical practice and health policy［J］.BMJ，2022，376：e067475.
ZHANG Y Q，LU L，XU N，et al.Increasing the usefulness of acupuncture guideline recommendations［J］.BMJ，2022，376：e070533.
LI H，JIN X，HERMAN P M，et al.Using economic evaluations to support acupuncture reimbursement decisions：Current evidence and gaps［J］.BMJ，2022，376：e067477.
HARNSBERGER C R，MAYKEL J A，ALAVI K.Postoperative ileus［J］.Clin Colon Rectal Surg，2019，32（3）：166-170.
MAZZOTTA E，VILLALOBOS-HERNANDEZ E C，FIORDA-DIAZ J，et al.Postoperative ileus and postoperative gastrointestinal tract dysfunction：Pathogenic mechanisms and novel treatment strategies beyond colorectal enhanced recovery after surgery protocols［J］.Front Pharmacol，2020，11：583422.
WU Z，BOERSEMA G S，DERECI A，et al.Clinical endpoint，early detection，and differential diagnosis of postoperative ileus：A systematic review of the literature［J］.Eur Surg Res，2015，54（3/4）：127-138.
DELANEY C P.Clinical perspective on postoperative ileus and the effect of opiates［J］.Neurogastroenterol Motil，2004，16（Suppl 2）：61-66.
BISANZ A，PALMER J L，REDDY S，et al.Characterizing postoperative paralytic ileus as evidence for future research and clinical practice［J］.Gastroenterol Nurs，2008，31（5）：336-344.
BATKE M，CAPPELL M S.Adynamic ileus and acute colonic pseudo-obstruction［J］.Med Clin North Am，2008，92（3）：649-670.
HOLTE K，KEHLET H.Postoperative ileus：A preventable event［J］.Br J Surg，2000，87（11）：1480-1493.
SOLANKI S，CHAKINALA R C，HAQ K F，et al.Paralytic ileus in the United States：A cross-sectional study from the national inpatient sample［J］.SAGE Open Med，2020，8：2050312120962636.
RAYNOR M C，PRUTHI R S.Postoperative ileus：Time for an evidence-based consensus［J］.Eur Urol，2013，64（4）：598-599.
GRECO M，CAPRETTI G，BERETTA L，et al.Enhanced recovery program in colorectal surgery：A meta-analysis of randomized controlled trials［J］.World J Surg，2014，38（6）：1531-1541.
ADAMINA M，KEHLET H，TOMLINSON G A，et al.Enhanced recovery pathways optimize health outcomes and resource utilization：A Meta-analysis of randomized controlled trials in colorectal surgery［J］.Surgery，2011，149（6）：830-840.
HAMEL J F，SABBAGH C，ALVES A，et al.Comparison of treatment to improve gastrointestinal functions after colorectal surgery within enhanced recovery programmes：A systematic review and Meta-analysis［J］.Sci Rep，2021，11（1）：7423.
MAO J J，PILLAI G G，ANDRADE C J，et al.Integrative oncology：Addressing the global challenges of cancer prevention and treatment［J］.CA Cancer J Clin，2022，72（2）：144-164.
YANG J W，WANG L Q，ZOU X，et al.Effect of acupuncture for postprandial distress syndrome：A randomized clinical trial［J］.Ann Intern Med，2020，172（12）：777-785.
NG S，LEUNG W W，MAK T，et al.Electroacupuncture reduces duration of postoperative ileus after laparoscopic surgery for colorectal cancer［J］.Gastroenterology，2013，144（2）：307-313.e1.
MENG Z Q，GARCIA M K，CHIANG J S，et al.Electro-acupuncture to prevent prolonged postoperative ileus：A randomized clinical trial［J］.World J Gastroenterol，2010，16（1）：104-111.
LIU Y H，DONG G T，YE Y，et al.Effectiveness of acupuncture for early recovery of bowel function in cancer：A systematic review and Meta-analysis［J］.Evid Based Complement Alternat Med，2017，2017：2504021.
CHEN K B，HUANG Y，JIN X L，et al.Electroacupuncture or transcutaneous electroacupuncture for postoperative ileus after abdominal surgery：A systematic review and meta-analysis［J］.Int J Surg，2019，70：93-101.
LIU Y，MAY B H，ZHANG A L，et al.Acupuncture and related therapies for treatment of postoperative ileus in colorectal cancer：A systematic review and Meta-analysis of randomized controlled trials［J］.Evid Based Complement Alternat Med，2018，2018：3178472.
ZHAO D，WU Z，ZHANG H，et al.Somatic symptoms vary in major depressive disorder in China［J］.Compr Psychiatry，2018，87：32-37.
WANG X，CHENG S，XU H.Systematic review and meta-analysis of the relationship between sleep disorders and suicidal behaviour in patients with depression［J］.BMC Psychiatry，2019，19（1）：303.
FANG H，TU S，SHENG J，et al.Depression in sleep disturbance：A review on a bidirectional relationship，mechanisms and treatment［J］.J Cell Mol Med，2019，23（4）：2324-2332.
YIN X，GOU M，XU J，et al.Efficacy and safety of acupuncture treatment on primary insomnia：A randomized controlled trial［J］.Sleep Med，2017，37：193-200.
YIN X，LI W，WU H，et al.Efficacy of electroacupuncture on treating depression-related insomnia：A randomized controlled trial［J］.Nat Sci Sleep，2020，12：497-508.
CAO Y，YAN Y J，XU J Y，et al.Acupuncture for insomnia after ischemic stroke：An assessor-participant blinded，randomized controlled trial［J］.Acupunct Med，2022，40（5）：443-452.
CHUNG K F，YEUNG W F，YU Y M，et al.Acupuncture for residual insomnia associated with major depressive disorder：A placebo- and sham-controlled，subject- and assessor-blind，randomized trial［J］.J Clin Psychiatry，2015，76（6）：e752-760.
TORRES J，MEHANDRU S，COLOMBEL J F，et al.Crohn's disease［J］.Lancet，2017，389（10080）：1741-1755.
OOI C J，HILMI I，BANERJEE R，et al.Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn's disease in Asia［J］.J Gastroenterol Hepatol，2019，34（8）：1296-1315.
RODA G，JHARAP B，NEERAJ N，et al.Loss of response to anti-TNFs：Definition，epidemiology，and management［J］.Clin Transl Gastroenterol，2016，7（1）：e135.
深化灸法机理研究促进灸法产业化--访上海中医药大学首席教授、上海市针灸经络研究所所长吴焕淦教授［J］.世界中医药，2016，11（12）：2829-2832.
BAO C，WU L，WANG D，et al.Acupuncture improves the symptoms，intestinal microbiota，and inflammation of patients with mild to moderate Crohn's disease：A randomized controlled trial［J］.EClinicalMedicine，2022，45：101300.
YOUNOSSI Z M，KOENIG A B，ABDELATIF D，et al.Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence，incidence，and outcomes［J］.Hepatology，2016，64（1）：73-84.
DANG Y，XU J，YANG Y，et al.Ling-gui-zhu-gan decoction alleviates hepatic steatosis through SOCS2 modification by N6-methyladenosine［J］.Biomed Pharmacother，2020，127：109976.
DAI L，XU J，LIU B，et al.Lingguizhugan decoction，a Chinese herbal formula，improves insulin resistance in overweight/obese subjects with non-alcoholic fatty liver disease：A translational approach［J］.Front Med，2022，16（5）：745-759.
TIAN Y，JIANG C，WANG M，et al.BMI，leisure-time physical activity，and physical fitness in adults in China：Results from a series of national surveys，2000-14［J］.Lancet Diabetes Endocrinol，2016，4（6）：487-497.
DAI L，WANG M，ZHANG K P，et al.Modified acupuncture therapy，long-term acupoint stimulation versus sham control for weight control：A multicenter，randomized controlled trial［J］.Front Endocrinol （Lausanne），2022，13：952373.
罗浩铭，刘学伟，张凤珠，等.从国家自然科学基金资助项目浅析中药药效物质研究概况［J］.中国中药杂志，2020，45（13）：3233-3237.
杨鹏挥，金丽君，廖杰，等.基于单细胞组学的中药现代研究：技术及思路［J］.中国中药杂志，2022，47（15）：3977-3985.
LIAO J，LU X，SHAO X，et al.Uncovering an organ's molecular architecture at single-cell resolution by spatially resolved transcriptomics［J］.Trends Biotechnol，2021，39（1）：43-58.
JIN K，GAO S，YANG P，et al.Single-cell rna sequencing reveals the temporal diversity and dynamics of cardiac immunity after myocardial infarction［J］.Small Methods，2022，6（3）：e2100752.
曾克武，屠鹏飞.中药作用靶点方法学研究进展［J］.中国科学：化学，2018，48（11）：1420-1428.
屠鹏飞，曾克武，廖理曦，等.天然活性小分子靶标蛋白识别方法学研究进展［J］.中国中药杂志，2016，41（1）：6-13.
LIU T T，YANG H，ZHUO F F，et al.Atypical E3 ligase ZFP91 promotes small-molecule-induced E2F2 transcription factor degradation for cancer therapy［J］.EBioMedicine，2022，86：104353.
ZHOU X，ZHAO S，LIU T，et al.Schisandrol A protects AGEs-induced neuronal cells death by allosterically targeting ATP6V0d1 subunit of V-ATPase［J］.Acta Pharm Sin B，2022，12（10）：3843-3860.
ZHANG X W，FENG N，LIU Y C，et al.Neuroinflammation inhibition by small-molecule targeting USP7 noncatalytic domain for neurodegenerative disease therapy［J］.Sci Adv，2022，8（32）：eabo0789.
曾克武，姜勇，王晶，等.中药化学生物学——“中药化学”与“生物学”交叉形成的新兴学科［J］.中国中药杂志，2019，44（5）：849-860.
LUO K，HUANG W，QIAO L，et al.Dendrocalamus latiflorus and its component rutin exhibit glucose-lowering activities by inhibiting hepatic glucose production via Akt activation［J］.Acta Pharm Sin B，2022，12（5）：2239-2251.
FENG J，YANG J，CHANG Y，et al.Caffeine-free hawk tea lowers cholesterol by reducing free cholesterol uptake and the production of very-low-density lipoprotein［J］.Commun Biol，2019，2：173.
LUO K，MA C，XING S，et al.White tea and its active polyphenols lower cholesterol through reduction of very-low-density lipoprotein production and induction of LDLR expression［J］.Biomed Pharmacother，2020，127：110146.
XIE L，FENG S，ZHANG X，et al.Biological response profiling reveals the functional differences of main alkaloids in Rhizoma Coptidis［J］.Molecules，2021，26（23）
FENG J，LI H，ZHAO W，et al.Biological-profiling-based systematic analysis of Rhizoma Coptidis from different growing regions and its anticholesterol biosynthesis activity on HepG2 cells［J］.Mol Pharm，2018，15（6）：2234-2245.
WHO.World malaria report 2022 ［M］.Geneva：World Health Organization，2022.
XU J，LIAO B，YUAN L，et al.50th anniversary of artemisinin：From the discovery to allele-aware genome assembly of Artemisia annua［J］.Mol Plant，2022，15（8）：1243-1246.
陈士林，向丽，李琳，等.青蒿素原料生产与资源再生全球战略研究［J］.科学通报，2017，62（18）：1982-1996.
LIAO B，SHEN X，XIANG L，et al.Allele-aware chromosome-level genome assembly of Artemisia annua reveals the correlation between ADS expansion and artemisinin yield［J］.Mol Plant，2022，15（8）：1310-1328.
WANG J，SONG H，GE F，et al.Landscape of DILI-related adverse drug reaction in China Mainland［J］.Acta Pharm Sin B，2022，12（12）：4424-4431.
GUO Y M，GE F L，SONG H B，et al.Relative risk analysis of liver-related adverse drug reactions in children based on China's national spontaneous reporting system［J］.J Pediatr，2021，234：85-91.
XIAO X H，TANG J Y，MAO Y M，et al.Guidance for the clinical evaluation of traditional Chinese medicine -induced liver injury issued by China Food and Drug Administration［J］. Acta Pharm Sin B，2019，9（3）：648-658.
WANG J B，HUANG A，WANG Y，et al.Corticosteroid plus glycyrrhizin therapy for chronic drug- or herb-induced liver injury achieves biochemical and histological improvements： A randomised open-label trial［J］.Aliment Pharmacol Ther，2022，55（10）：1297-1310.
WANG J，MA Z，NIU M，et al.Evidence chain-based causality identification in herb-induced liver injury： Exemplification of a well-known liver-restorative herb Polygonum multiflorum［J］.Front Med，2015，9（4）：457-467.
王伽伯，张乐，郭玉明，等.中药药源性肝损伤因果关系的评价策略和方法［J］.药学学报，2018，53（6）：920-928.
WANG J B，ZHU Y，BAI Z F，et al.Guidelines for the diagnosis and management of herb-induced liver injury［J］.Chin J Integr Med，2018，24（9）：696-706.
Council of International Organizations of Medical Sciences.Drug-induced liver injury （DILI）：Current status and future directions for drug development and the post-market setting［EB/OL］.［2023-05-18］.https：//cioms.ch/publications/product/drug-induced-liver-injury/https://cioms.ch/publications/product/drug-induced-liver-injury/.
王伽伯，崔鹤蓉，柏兆方，等.精准医学下的中药安全性评价策略和方法：病证毒理学［J］.药学学报，2016，51（11）：1681-1688.
柏兆方，王伽伯，肖小河.中药毒性认知创新与安全精准用药［J］.中国中药杂志，2022，47（10）：2557-2564.
TONG J，GAO J，LIU Q，et al.Resveratrol derivative excited postsynaptic potentiation specifically via PKCβ-NMDA receptor mediation［J］.Pharmacol Res，2020，152：104618.
TU C，NIU M，WEI A W，et al.Susceptibility-related cytokine panel for prediction of Polygonum multiflorum-induced hepatotoxicity in humans［J］.J Inflamm Res，2021，14：645-655.
ZHANG L，NIU M，WEI A W，et al.Clinical correlation between serum cytokines and the susceptibility to Polygonum multiflorum-induced liver injury and an experimental study［J］.Food Funct，2022，13（2）：825-833.
ZHANG L，NIU M，WEI A W，et al.Risk profiling using metabolomic characteristics for susceptible individuals of drug-induced liver injury caused by Polygonum multiflorum［J］.Arch Toxicol，2020，94（1）：245-256.
LI C，RAO T，CHEN X，et al.HLA-B*35∶01 allele is a potential biomarker for predicting Polygonum multiflorum-induced liver injury in humans［J］.Hepatology，2019，70（1）：346-357.
MA Z T，SHI Z，XIAO X H，et al.New insights into herb-induced liver injury［J］.Antioxid Redox Signal，2023，38（16/18）：1138-1149.
中华中医药学会中成药分会，中华中医药学会肝胆病分会，中国药学会临床中药学专业委员会，等.何首乌安全用药指南［J］.中国中药杂志，2020，45（5）：961-966.
宋海波，沈传勇.中药安全用药与风险防控的探索及实践——以何首乌为例的安全风险管理［J］.中国食品药品监管，2020（12）：12-18.
LI P，CHEN Y，LIU J，et al.Efficacy and safety of tangshen formula on patients with type 2 diabetic kidney disease：A multicenter double-blinded randomized placebo-controlled trial［J］.PLoS One，2015，10（5）：e0126027.
YAN M，WEN Y，YANG L，et al.Chinese herbal medicine Tangshen formula treatment of patients with type 2 diabetic kidney disease with macroalbuminuria：Study protocol for a randomized controlled trial［J］.Trials，2016，17（1）：259.
YANG X，ZHANG B，LU X，et al.Effects of Tangshen formula on urinary and plasma liver-type fatty acid binding protein levels in patients with type 2 diabetic kidney disease：Post-hoc findings from a multi-center，randomized，double-blind，placebo-controlled trial investigating the efficacy and safety of Tangshen Formula in patients with type 2 diabetic kidney disease［J］.BMC Complement Altern Med，2016，16：246.
LIU P，PENG L，ZHANG H，et al.Tangshen formula attenuates diabetic nephropathy by promoting ABCA1-mediated renal cholesterol efflux in db/db mice［J］.Front Physiol，2018，9：343.
WANG Y，ZHAO H，LI X，et al.Tangshen formula alleviates hepatic steatosis by inducing autophagy through the AMPK/SIRT1 pathway［J］.Front Physiol，2019，10：494.
ZHAO T，ZHANG H，YIN X，et al.Tangshen formula modulates gut microbiota and reduces gut-derived toxins in diabetic nephropathy rats［J］.Biomed Pharmacother，2020，129：110325.
CHEN P，ZHAO J，ZHANG H，et al.Tangshen formula attenuates colonic structure remodeling in type 2 diabetic rats［J］.Evid Based Complement Alternat Med，2017，2017：4064156.
HU L，WANG Y，WAN Y，et al.Tangshen formula improves diabetes-associated myocardial fibrosis by inhibiting TGF-β/Smads and Wnt/β-Catenin pathways［J］.Front Med （Lausanne），2021，8：732042.
CHEN P M，ZHAO J B，YANG X，et al.Protective effect of Tangshen formula （糖肾方） on interstitial cells of Cajal in colon of diabetic rats［J］.Chin J Integr Med，2022，28（1）：43-51.
ZHANG B，WAN Y，ZHOU X，et al.Characteristics of serum metabolites and gut microbiota in diabetic kidney disease［J］.Front Pharmacol，2022，13：872988.
LI N，ZHAO T，CAO Y，et al.Tangshen formula attenuates diabetic kidney injury by imparting anti-pyroptotic effects via the TXNIP-NLRP3-GSDMD Axis［J］.Front Pharmacol，2020，11：623489.
刘鹏，申正日，王晨，等.糖肾方调控FXR/vimentin/α-SMA通路减轻糖尿病肾脏疾病肾脏纤维化的研究［J］.北京中医药大学学报，2022，45（12）：1196-1204.
GAO J，LIU P，SHEN Z，et al.Morroniside promotes PGC-1α-mediated cholesterol efflux in sodium palmitate or high glucose-induced mouse renal tubular epithelial cells［J］.Biomed Res Int，2021，2021：9942152.
0
Views
26
下载量
0
CSCD
- H-PDFDownload
- L-PDFDownload
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Publicity Resources
Related Articles
Related Author
Related Institution
- Postal code：100700
- Tel：010-84076882 Email：syfjx_2010@188.com
- Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10
京公网安备11010802024621 - It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
- Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.
